Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biodermis is a private U.S. skin health company focused on scar management and post-operative care products. Its portfolio is commercial-stage and includes silicone gel sheeting, silicone scar sticks, topical scar gels and ointments, post-liposuction compression foam, and skincare products sold to both medical professionals and consumers. The company is particularly known for Epi-Derm silicone gel sheeting, Pro-Sil silicone scar sticks, Xeragel, and BIOCORNEUM products for scar appearance management and skin recovery. Biodermis appears to operate primarily as a medical device and professional skincare company rather than a drug-development biotech, with emphasis on topical silicone-based scar care and aesthetic/post-surgical recovery solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biodermis.